Juerg Gasser Email & Phone Number | Jürg Andreas Gasser is Head of Biomarker Research for the Musculoskeletal Disease area at Novartis Institutes for BioMedical Research, covering regenerative programs in bone, cartilage, tendon and peripheral nerve. He graduated from the University of Bern, Switzerland, and obtained his PhD in Biochemistry from the Faculty of Science at University College London, UK. His main focus is the understanding of disease pathologies, discovery of novel targets, and development of regenerative pharmacological- and gene-therapies that, in combination with digital tools, aim to restore mobility and independence of patients affected by musculoskeletal diseases and injuries. Jürg Gasser was founder and President of the International Society of Musculoskeletal and Neuronal Interactions and a member of the Board of Directors of the International Society of Bone Morphometry, the International Society of Musculoskeletal and Neuronal Interactions, the Swiss Bone and Mineral Society and the Asia Pacific Society for Bone Morphometry. He has published 116 peer-reviewed articles, 3 book chapters, and given 72 invited lectures and 90 oral communications (4784 citations and a H-index of 31 according to Google Scholar). Dr. Gasser acts as a referee for numerous scientific journals, is Scientific Editor of European Cells and Materials, and on the Editorial Board of Bone, Calcified Tissue International and Journal of Orthopaedic Translation. He is also a registered musculoskeletal disease expert for the EU Framework Program grant evaluations, as well as for many national funding schemes throughout Europe.

Juerg Gasser

Jürg Andreas Gasser is Head of Biomarker Research for the Musculoskeletal Disease area at Novartis I...
Basel, Basel, Switzerland

*50 free lookup(s) per month.

No credit card required.

Juerg Gasser’s Email juerg.gasser@novartis.com

Juerg Gasser’s Phone Numbers +1 212-830-****

Get JUERG’s Phone Number (For Free)

Social Media

Juerg Gasser’s Location Basel, Basel, Switzerland

Juerg Gasser’s Current Industry Novartis Institutes For Biomedical Research

Juerg Gasser’s Prior Industry

Not the Juerg Gasser you were looking for?

Find accurate emails & phone numbers for over 700M professionals.

Work Experience

Novartis

Associate Director, Msd Management

Present

Novartis Institutes For Biomedical Research

Associate Director, Msd Management

2020-02-01 00:00:00 - Present

Skills

No Skills Available

Languages

No Languages Available

FAQ About Juerg Gasser

Juerg Gasser is located at
Basel, Basel, Switzerland

Juerg Gasser is a Jürg Andreas Gasser is Head of Biomarker Research for the Musculoskeletal Disease area at Novartis Institutes for BioMedical Research, covering regenerative programs in bone, cartilage, tendon and peripheral nerve. He graduated from the University of Bern, Switzerland, and obtained his PhD in Biochemistry from the Faculty of Science at University College London, UK. His main focus is the understanding of disease pathologies, discovery of novel targets, and development of regenerative pharmacological- and gene-therapies that, in combination with digital tools, aim to restore mobility and independence of patients affected by musculoskeletal diseases and injuries. Jürg Gasser was founder and President of the International Society of Musculoskeletal and Neuronal Interactions and a member of the Board of Directors of the International Society of Bone Morphometry, the International Society of Musculoskeletal and Neuronal Interactions, the Swiss Bone and Mineral Society and the Asia Pacific Society for Bone Morphometry. He has published 116 peer-reviewed articles, 3 book chapters, and given 72 invited lectures and 90 oral communications (4784 citations and a H-index of 31 according to Google Scholar). Dr. Gasser acts as a referee for numerous scientific journals, is Scientific Editor of European Cells and Materials, and on the Editorial Board of Bone, Calcified Tissue International and Journal of Orthopaedic Translation. He is also a registered musculoskeletal disease expert for the EU Framework Program grant evaluations, as well as for many national funding schemes throughout Europe.